| CAS No. | 937272-79-2 |
|---|---|
| MDL No. | MFCD22572772 |
| MF | C28H32N4O3 |
| MW | 472.60 |
| InChI Key | HWXVIOGONBBTBY-ONEGZZNKSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Pacritinib (C28H32N4O3) is an azamacrocycle and a Janus kinase inhibitor, approved as its citrate salt for treating intermediate or high-risk primary or secondary myelofibrosis. It functions as an EC 2.7.10.2 inhibitor, an antineoplastic agent, apoptosis inducer, and anti-inflammatory agent. It belongs to the classes of pyrrolidines, cyclic ethers, and benzenes, and is the conjugate base of pacritinib(1+).
| CAS No. | 937272-79-2 |
|---|---|
| Product Name | Pacritinib |
Health Hazard
Environmental Hazard